According to Zhitong Finance App, Beihai Kangcheng-B (01228.HK) issued an announcement. Malibai, which treats Alagelli syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC), has been approved by the Taiwan Health Insurance Department to be included in health insurance payments. The relevant health insurance payments will officially take effect on September 1, 2026.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.